imperial innovations group p
(N8R:Berlin Stock Exchange)
Transactions by IMPERIAL INNOVATIONS GROUP P (N8R) in the last 6 months
Apple Europe Ltd acquired Semetric Limited from Imperial Innovations Group plc (AIM:IVO) and Pentech Ventures recently. For the year ended 2013, Semetric posted loss of £1.4 million and net assets of £1.3 million. Imperial Innovations sold 27.3% stake in Semetric. Post acquisition, Semetric Limited will change its registered office.
Veryan Medical, Ltd. announced that it has received £18 million in its series B round of equity funding led by existing investor Imperial Innovations Group plc on January 14, 2015. The transaction included participation from Seven Mile Capital Partners, INVESCO Asset Management Limited, and existing investor Seroba Kernel Life Sciences Limited. Imperial Innovations Group plc invested £8.40 million in the transaction. Post the closing of the transaction, Imperial Innovations ...
INVESCO Asset Management Limited
Seroba Kernel Life Sciences Limited
Seven Mile Capital Partners
Abingdon Health Ltd acquired remaining 45% stake in Molecular Vision Limited from Imperial Innovations Group plc (AIM:IVO) and others on January 8, 2015.
Cell Medica Limited announced that it has received £50 million in series B round of funding on November 25, 2014. The transaction was led by existing investor, Imperial Innovations Group plc for £15 million and included the participation from existing investor Invesco Perpetual, Woodford Investment Management. Pursuant to the transaction, Imperial Innovations Group will hold 27.9% stake in the company. Rob Wood, Partner and Caroline Drummond, Senior Associate at Osborne ...
Woodford Investment Management LLP
Kesios Therapeutics Limited announced that it has received £1.85 million in its seed round of equity funding from new investor Imperial Innovations Group plc on October 8, 2014. As a part of the round, the investor acquired a total of 48.4% stake in the company.
Inivata Limited announced that it has received £4 million in its first round of funding led by new investor Imperial Innovations Group plc on September 23, 2014. The transaction included participation from new investors Cambridge Innovation Capital PLC which invested £1.5 million and Johnson & Johnson Development Corporation.
Imperial Innovations Group plc
Johnson & Johnson Development Corporation
|Health Discovery Corp||$0.02 USD||0.00|
|Miraculins Inc||C$0.18 CAD||+0.005|
|Myriad Genetics Inc||$34.79 USD||+0.49|
|Vermillion Inc||$1.77 USD||-0.0199|
|View Industry Companies|